| Cell senescence in rat kidneys in vivo increases with growth and age despite lack of telomere shortening A Melk, W Kittikowit, I Sandhu, KM Halloran, P Grimm, BMW Schmidt, ... Kidney international 63 (6), 2134-2143, 2003 | 223 | 2003 |
| Molecular assessment of rejection and injury in lung transplant biopsies KM Halloran, MD Parkes, J Chang, IL Timofte, GI Snell, GP Westall, ... The Journal of Heart and Lung Transplantation 38 (5), 504-513, 2019 | 52 | 2019 |
| Banff Lung Report: current knowledge and future research perspectives for diagnosis and treatment of pulmonary antibody-mediated rejection (AMR) A Roux, DJ Levine, A Zeevi, R Hachem, K Halloran, PF Halloran, ... American Journal of Transplantation 19 (1), 21-31, 2019 | 52 | 2019 |
| Lung transplantation from hepatitis C viremic donors to uninfected recipients A Abdelbasit, A Hirji, K Halloran, J Weinkauf, A Kapasi, D Lien, ... American Journal of Respiratory and Critical Care Medicine 197 (11), 1492-1496, 2018 | 45 | 2018 |
| Comprehensive outcomes after lung retransplantation: A single‐center review K Halloran, M Aversa, K Tinckam, T Martinu, M Binnie, C Chaparro, ... Clinical transplantation 32 (6), e13281, 2018 | 42 | 2018 |
| Baseline lung allograft dysfunction is associated with impaired survival after double-lung transplantation J Liu, K Jackson, J Weinkauf, A Kapasi, A Hirji, S Meyer, J Mullen, ... The Journal of Heart and Lung Transplantation 37 (7), 895-902, 2018 | 37 | 2018 |
| Molecular phenotyping of rejection-related changes in mucosal biopsies from lung transplants K Halloran, MD Parkes, IL Timofte, GI Snell, GP Westall, R Hachem, ... American Journal of Transplantation 20 (4), 954-966, 2020 | 36 | 2020 |
| Non‐tuberculous mycobacteria in lung transplant recipients: Prevalence, risk factors, and impact on survival and chronic lung allograft dysfunction DZP Friedman, C Cervera, K Halloran, G Tyrrell, K Doucette Transplant infectious disease 22 (2), e13229, 2020 | 29 | 2020 |
| Income status and approval for bariatric surgery in a publicly funded regional obesity program K Halloran, RS Padwal, C Johnson-Stoklossa, AM Sharma, DW Birch Obesity surgery 21, 373-378, 2011 | 28 | 2011 |
| Azithromycin prophylaxis after lung transplantation is associated with improved overall survival D Li, Q Duan, J Weinkauf, A Kapasi, R Varughese, A Hirji, D Lien, ... The Journal of Heart and Lung Transplantation 39 (12), 1426-1434, 2020 | 22 | 2020 |
| Association between Mycoplasma and Ureaplasma airway positivity, ammonia levels, and outcomes post–lung transplantation: a prospective surveillance study BF Buzo, JK Preiksaitis, K Halloran, J Nagendran, DR Townsend, ... American Journal of Transplantation 21 (6), 2123-2131, 2021 | 21 | 2021 |
| Clinical transplantation using negative pressure ventilation ex situ lung perfusion with extended criteria donor lungs MT Buchko, N Boroumand, JC Cheng, A Hirji, K Halloran, DH Freed, ... Nature Communications 11 (1), 5765, 2020 | 18 | 2020 |
| Outcomes of lung transplantation in recipients with hepatitis C virus infection KE Doucette, K Halloran, A Kapasi, D Lien, JG Weinkauf American Journal of Transplantation 16 (8), 2445-2452, 2016 | 18 | 2016 |
| Case report of vertebral osteomyelitis and mycotic abdominal aortic aneurysm caused by Scedosporium apiospermum in a lung transplant patient with cystic fibrosis S Thomson, K Alibhai, G Winkelaar, D Lien, K Halloran, A Kapasi, ... Transplantation Proceedings 47 (1), 204-209, 2015 | 18 | 2015 |
| Molecular T-cell‒mediated rejection in transbronchial and mucosal lung transplant biopsies is associated with future risk of graft loss K Halloran, MD Parkes, I Timofte, G Snell, G Westall, J Havlin, R Lischke, ... The Journal of Heart and Lung Transplantation 39 (12), 1327-1337, 2020 | 17 | 2020 |
| Clinical judgment versus lung allocation score in predicting lung transplant waitlist mortality A Hirji, H Zhao, MB Ospina, JS Lomelin, K Halloran, M Hubert, J Yee, ... Clinical Transplantation 34 (7), e13870, 2020 | 17 | 2020 |
| Coronary artery disease and coronary artery bypass grafting at the time of lung transplantation do not impact overall survival K Halloran, A Hirji, D Li, K Jackson, A Kapasi, S Meyer, J Mullen, D Lien, ... Transplantation 103 (10), 2190-2195, 2019 | 15 | 2019 |
| Chest X-ray sizing for lung transplants reflects pulmonary diagnosis and body composition and is associated with primary graft dysfunction risk D Li, J Weinkauf, A Hirji, J Nagendran, A Kapasi, D Lien, K Halloran Transplantation 105 (2), 382-389, 2021 | 14 | 2021 |
| Elevated pre-transplant left ventricular end-diastolic pressure increases primary graft dysfunction risk in double lung transplant recipients D Li, J Weinkauf, A Hirji, A Kapasi, D Lien, J Nagendran, D Kim, ... The Journal of Heart and Lung Transplantation 38 (7), 710-718, 2019 | 14 | 2019 |
| Impact of donor and recipient cytomegalovirus serology on long‐term survival of lung transplant recipients C Mabilangan, J Preiksaitis, C Cervera, ... Transplant Infectious Disease 20 (5), e12964, 2018 | 14 | 2018 |
Philip F HalloranProfessor of Medicine, University of AlbertaVerified email at ualberta.ca
